SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000946644-15-000013
Filing Date
2015-05-12
Accepted
2015-05-12 16:02:39
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q heb-2015033110q.htm 10-Q 734051
2 EXHIBIT 31.1 heb-20150331xex311.htm EX-31.1 13340
3 EXHIBIT 31.2 heb-20150331xex312.htm EX-31.2 13407
4 EXHIBIT 32.1 heb-20150331xex321.htm EX-32.1 6575
5 EXHIBIT 32.2 heb-20150331xex322.htm EX-32.2 6676
  Complete submission text file 0000946644-15-000013.txt   5253069

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT heb-20150331.xml EX-101.INS 786522
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT heb-20150331.xsd EX-101.SCH 33898
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT heb-20150331_cal.xml EX-101.CAL 50669
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT heb-20150331_def.xml EX-101.DEF 125161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT heb-20150331_lab.xml EX-101.LAB 418668
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT heb-20150331_pre.xml EX-101.PRE 228743
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 15854424
SIC: 2836 Biological Products, (No Diagnostic Substances)